YARMOLINSKY J, BOURAS E, CONSTANTINESCU A, et al. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia. 2023 May 12. doi: 10.1007/s00125-023-05925-4
PLATAFORMA EN RED BANCO ADN CARLOS III
YARMOLINSKY J, BOURAS E, CONSTANTINESCU A, et al. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia. 2023 May 12. doi: 10.1007/s00125-023-05925-4
© 2026 Banco Nacional de ADN / Desarrollado por CREALOGO